Suppr超能文献

鉴定和阐明 10 碳脂肪酸作为过氧化物酶体增殖物激活受体的调节配体的机制。

Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors.

机构信息

Laboratories of Structural Sciences, Van Andel Research Institute, Grand Rapids, Michigan, 49503.

Laboratory of Microarray Technology, Van Andel Research Institute, Grand Rapids, Michigan, 49503; Laboratory of Analytical, Cellular, and Molecular Microscopy, Van Andel Research Institute, Grand Rapids, Michigan 49503.

出版信息

J Biol Chem. 2012 Jan 2;287(1):183-195. doi: 10.1074/jbc.M111.294785. Epub 2011 Oct 28.

Abstract

Peroxisome proliferator-activated receptors (PPARα, -β/δ, and -γ) are a subfamily of nuclear receptors that plays key roles in glucose and lipid metabolism. PPARγ is the molecular target of the thiazolidinedione class of antidiabetic drugs that has many side effects. PPARγ is also activated by long chain unsaturated or oxidized/nitrated fatty acids, but its relationship with the medium chain fatty acids remains unclear even though the medium chain triglyceride oils have been used to control weight gain and glycemic index. Here, we show that decanoic acid (DA), a 10-carbon fatty acid and a major component of medium chain triglyceride oils, is a direct ligand of PPARγ. DA binds and partially activates PPARγ without leading to adipogenesis. Crystal structure reveals that DA occupies a novel binding site and only partially stabilizes the AF-2 helix. DA also binds weakly to PPARα and PPARβ/δ. Treatments with DA and its triglyceride form improve glucose sensitivity and lipid profiles without weight gain in diabetic mice. Together, these results suggest that DA is a modulating ligand for PPARs, and the structure can aid in designing better and safer PPARγ-based drugs.

摘要

过氧化物酶体增殖物激活受体 (PPARα、-β/δ 和 -γ) 是核受体的一个亚家族,在葡萄糖和脂质代谢中发挥关键作用。PPARγ 是噻唑烷二酮类抗糖尿病药物的分子靶点,这类药物有许多副作用。长链不饱和或氧化/硝化脂肪酸也会激活 PPARγ,但它与中链脂肪酸的关系仍不清楚,尽管中链甘油三酯油已被用于控制体重增加和血糖指数。在这里,我们表明,癸酸 (DA),一种 10 碳脂肪酸,也是中链甘油三酯油的主要成分,是 PPARγ 的直接配体。DA 结合并部分激活 PPARγ,而不会导致脂肪生成。晶体结构揭示 DA 占据了一个新的结合位点,仅部分稳定 AF-2 螺旋。DA 也与 PPARα 和 PPARβ/δ 弱结合。在糖尿病小鼠中,用 DA 及其甘油三酯形式进行治疗可改善葡萄糖敏感性和脂质谱,而不会增加体重。总之,这些结果表明 DA 是 PPARs 的调节配体,该结构有助于设计更好、更安全的基于 PPARγ 的药物。

相似文献

1
Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors.
J Biol Chem. 2012 Jan 2;287(1):183-195. doi: 10.1074/jbc.M111.294785. Epub 2011 Oct 28.
4
Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging.
Prostaglandins Leukot Essent Fatty Acids. 2016 Nov;114:28-34. doi: 10.1016/j.plefa.2016.10.001. Epub 2016 Oct 6.
5
PPARs and angiogenesis.
Biochem Soc Trans. 2011 Dec;39(6):1601-5. doi: 10.1042/BST20110643.
7
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Circ Res. 2004 May 14;94(9):1168-78. doi: 10.1161/01.RES.0000127122.22685.0A.
8
Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
Acta Physiol (Oxf). 2008 Sep;194(1):57-65. doi: 10.1111/j.1748-1716.2008.01860.x. Epub 2008 Apr 3.
9
The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.
Mol Endocrinol. 2006 Jun;20(6):1261-75. doi: 10.1210/me.2006-0025. Epub 2006 Mar 23.
10
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Pharmacol Rev. 2006 Dec;58(4):726-41. doi: 10.1124/pr.58.4.5.

引用本文的文献

1
A medium-chain fatty acid analogue prevents endotoxin liver injury in a murine model.
Sci Rep. 2025 Apr 20;15(1):13645. doi: 10.1038/s41598-025-98200-y.
3
Association of dietary decanoic acid intake with diabetes or prediabetes: an analysis from NHANES 2005-2016.
Front Nutr. 2025 Jan 7;11:1483045. doi: 10.3389/fnut.2024.1483045. eCollection 2024.
5
Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression.
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2321874121. doi: 10.1073/pnas.2321874121. Epub 2024 Aug 29.
6
Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets.
Biomolecules. 2024 Aug 13;14(8):998. doi: 10.3390/biom14080998.
9
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ.
bioRxiv. 2024 Sep 12:2024.05.15.594037. doi: 10.1101/2024.05.15.594037.
10
Medium-Chain Triglycerides (MCTs) for the Symptomatic Treatment of Dementia-Related Diseases: A Systematic Review.
J Nutr Metab. 2024 Apr 12;2024:9672969. doi: 10.1155/2024/9672969. eCollection 2024.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.
J Biol Chem. 2011 May 6;286(18):16074-81. doi: 10.1074/jbc.M111.225029. Epub 2011 Mar 15.
4
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
Nature. 2010 Jul 22;466(7305):451-6. doi: 10.1038/nature09291.
6
Diabetes in Asia: epidemiology, risk factors, and pathophysiology.
JAMA. 2009 May 27;301(20):2129-40. doi: 10.1001/jama.2009.726.
7
INT131: a selective modulator of PPAR gamma.
J Mol Biol. 2009 Mar 13;386(5):1301-11. doi: 10.1016/j.jmb.2009.01.025.
9
Structural basis for the activation of PPARgamma by oxidized fatty acids.
Nat Struct Mol Biol. 2008 Sep;15(9):924-31. doi: 10.1038/nsmb.1474.
10
Standards of medical care in diabetes--2009.
Diabetes Care. 2009 Jan;32 Suppl 1(Suppl 1):S13-61. doi: 10.2337/dc09-S013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验